Oppenheimer analyst Jay Olson raised the price target on TherapeuticsMD (NASDAQ: TXMD) to $14.00 (from $12.00) while maintaining an Outperform ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE